PIM is also synthetic lethal in models of MYC-dependent, hormone naive breast cancer [122] and small-molecule PIM inhibitors are effective in limiting MYC-driven breast cancer cell growth in vivo [123]. This evidence concerns the gene MYC and breast carcinoma.